Page 4 - Now Pfizer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

They're on a pressured timeline but not going to overlook their process. then we do need these advisory committees to meet. they'll meet quickly. we talked about dr. gottlieb saying before hall wean. i would put it hall wean to thanksgiving, and 5 to 11. under 5, you would expect to follow two to three months. that could be somewhere between december and february, based on the enrollment and the data. that's for pfizer. moderna is still behind that. and johnson & johnson is in trial, but it could be months before we see that data. >> dr. kavita patel, thank you. gabe gutierrez, thank you to yo...

Not because of any waning protection, hallie. this is still highly controversial among public health officials. again, tomorrow, pfizer is expected to discuss its data with that panel of outside experts. the fda will make its recommendation, hallie. >> gabe, thank you. let me turn to you, doctor. pull out your doctor to plain english translation sheet here. i know you read through that briefing document. talk to us about what the data shows. is it possible they land somewhere in the middle tomorrow? some people need boosters, some people don't. >> yeah, hallie, that is the right question to as...

Prioritized? from a process standpoint, hallie, we'll have an advisory committee meeting tomorrow. the fda needs to take action. and then the cdc still has to meet at their advisory committee and put out recommendation. i just don't think we'll see booster shots at 8:00 a.m. on monday morning is the bottom line. >> okay. talk about -- you mentioned kids. talk about kids ages 5 to 11. pfizer's ceo says that data could be ready to submit by the end of the month and really little kids 6 months to 5 years old later. where does this put us on timing from the fda? i have heard things like this fall,...

Ready to launch next week. gabe gutierrez is outside headquarters in washed and we've got medical contributor dr. kavita patel with us, adviser in the obama administration. it is perhaps in the realm of possibility that the fda does not recommend boosters for the general public yet after tomorrow's meeting. you have the biden administration still previewing the launch of this booster campaign starting next week. what's the deal? >> reporter: hey there, hallie. yes, it's highly controversial. yes, as you mentioned, last month the biden administration put forward a plan that vaccine boosters wou...

Este lunes la Administración de Medicamentos y Alimentos (FDA) aprobó de forma total la vacuna contra Covid-19 de la farmacéutica Pfizer, cuyo nombre comercial es Comirnaty. Pero, ¿qué signifi